Drug shortages have surged to their highest levels in decades. In early 2024, U.S. pharmacies reported more than 323 active shortages, spanning essential generics, injectables, and even critical cancer therapies. These numbers echo findings from the American Society of Health-System Pharmacists, which tracks persistent disruptions that ripple through hospitals, pharmacies, and ultimately to patients in urgent need of care.
While the pandemic made those cracks impossible to ignore, the reality
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
How Horizon Health and Qure.ai Are Using AI to Catch “Incidental” Lung Cancer
What You Should Know:
- Horizon Health Network, operating across New Brunswick, Canada, has partnered with global health tech leader Qure.ai to implement a comprehensive AI suite for lung cancer care.
- The strategic collaboration is designed to prepare the health system for a province-wide screening program while simultaneously deploying AI to detect "incidental" lung nodules in routine X-rays and CT scans. By integrating tools for detection, quantification, and patient
Read More
2026 Healthcare Executive Predictions: Why the AI “Pilot Era” Is Officially Over
If the last two years were defined by the breathless hype of experimentation, 2026 marks the healthcare industry’s decisive transition from "flashy, one-off experiments" to "top-down programs designed for measurable impact". Across the digital health landscape, executives agree that the "pilot era is ending," with the focus shifting entirely to systems that can be "governed, audited, and trusted" at scale.
The narrative for the coming year is no longer about the novelty of generative AI
Read More
PwC 2026 Outlook: Health Services M&A Poised for Rebound as AI Becomes “Core Driver” of Value
What You Should Know:
- According to PwC's 2026 Health Services Deals Outlook, the M&A market is set to regain momentum in both deal value and volume after a cooling period in 2025.
- The report highlights a strategic pivot among private equity investors away from reimbursement-heavy assets toward AI-enabled software and services that drive margin expansion without adding labor. With the IPO window reopening and "mega-funds" returning to offense, the winners in 2026 will be
Read More
The Healthcare Balancing Act: How AI, RPM, and Predictive Analytics Cut Costs Without Sacrificing Care
Calling healthcare a balancing act is probably not doing it justice: Costs are rising, reimbursements are dwindling, and Medicaid is under the knife, but health organizations are still tasked with providing the highest quality of care to the most people they can without breaking the bank.
Under unprecedented financial strain, providers and payers need to optimize operations and trim the budget wherever they can, but never at the expense of quality patient care. That’s why many are investing
Read More
Tampa General Hospital Partners with Reimagine Care to Launch AI-Enabled Virtual Oncology Support
What You Should Know:
- Tampa General Hospital (TGH) Cancer Institute has partnered with Reimagine Care to integrate an AI-enabled virtual cancer care program into its clinical pathways.
- The collaboration, backed by an investment from TGH Ventures, provides 24/7 symptom monitoring and triage to reduce emergency department visits and administrative burden on oncologists. This move aims to expand capacity and improve patient outcomes across Florida, a state facing 115,000 new
Read More
Ritten Raises $35M to Scale AI-Powered Behavioral Health Platform
What You Should Know:
- Ritten, a leading AI-powered system of record for behavioral health providers, today announced a $35 million USD Series B funding round led by Five Elms Capital with participation from existing investors Threshold Ventures, 8VC, Bienville Capital, and others.
- This investment will support Ritten's expansion across mental health and addiction treatment providers spanning all levels of care.
A Unified Platform Purpose-Built for Behavioral Health
Read More
OpenAI-Backed Chai Discovery Raises $130M to Tackle “Undruggable” Targets with Generative AI
What You Should Know:
- Chai Discovery has secured a $130M Series B financing round, propelling its valuation to $1.3 billion just months after emerging from stealth.
- Co-led by Oak HC/FT and General Catalyst, the funding validates Chai’s proprietary AI models, which can predict biochemical interactions and design drugs for targets previously considered "undruggable."
- With backing from industry heavyweights like OpenAI and Thrive Capital, Chai is positioning itself
Read More
Philips Acquires SpectraWAVE to “Double Down” on AI-Powered Coronary Imaging
What You Should Know:
- Philips has agreed to acquire SpectraWAVE, Inc., a move designed to bolster its leadership in image-guided therapy by integrating SpectraWAVE’s AI-powered coronary imaging and physiology assessments into the Philips Azurion platform.
- The acquisition adds critical next-generation capabilities, including DeepOCT (optical coherence tomography) and wire-free Fractional Flow Reserve (FFR), to Philips' existing portfolio.
- The strategic expansion aims to
Read More
Moving Beyond the Worklist: Agentic AI and Radiology’s Next Efficiency Leap
After years of flat or falling payment rates, radiology providers are being asked to do more with less. Medicare cuts continue to squeeze margins, and inflation-driven cost hikes in labor and supplies further strain budgets. At the same time, workforce shortages have left many radiology departments shorthanded and clinicians overextended. Meanwhile, the traditional follow-up worklist-centric model—essentially a growing to-do list of patients needing outreach, navigation, and scheduling—is
Read More
